28.36  0.51 (1.83%)		02-13 16:00
Open: 28.22 High: 29.15 Volume: 2,937,246		Pre. Close: 27.85 Low: 28.08 Market Cap: 1,144(M)

Short term
Mid term
Targets	6-month :	37.03	1-year :	40.16
Resists	First :	31.7	Second :	34.38
Pivot price	29.84
Supports	First :	27.36	Second :	22.76
MAs	MA(5) :	28.63	MA(20) :	30.52
	MA(100) :	30.07	MA(250) :	26.16
MACD	MACD :	-0.8	Signal :	-0.5
%K %D	K(14,3) :	14.6	D(3) :	18.3
RSI	RSI(14): 40.1
52-week	High :	34.38	Low :	17.5

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
[ ARKG ] has closed above bottom band by 25.7%. Bollinger Bands are 30.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	29.16 - 29.31	29.31 - 29.45
Low:	27.75 - 27.89	27.89 - 28.04
Close:	28.12 - 28.36	28.36 - 28.59

The fund is an actively-managed exchange-traded fund ("ETF") that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution ("Genomics Revolution Companies"). It is non-diversified.

Wed, 11 Feb 2026
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - US News Money

Wed, 28 Jan 2026
ARKG: Cathie Wood's Biotech Product Is In Rally Mode (BATS:ARKG) - Seeking Alpha

Fri, 23 Jan 2026
Friday's ETF Movers: SLVR, ARKG - Nasdaq

Tue, 06 Jan 2026
Cathie Wood Loads Up On Tempus AI And This George Soros-Backed Company's Stock, Dumps Roku And Shopify Shares - Sahm

Mon, 05 Jan 2026
Cathie Wood’s ARK Invest Shifts 2026 Strategy, Heavily Bets on Gene Editing Technology - NAI500

Sat, 27 Dec 2025
Cathie Wood Doubles Down on Self-Driving and Gene-Editing Stocks Ahead of 2026 - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: CBOE
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.